Schedule 13G ownership disclosure
ANEBULO PHARMACEUTICALS INC
Common Stock · CUSIP: 034569103
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mangrove Partners IM, LLC
Shares: 2,525,252.00 · Class: 6.15%
- Nathaniel August
Shares: 2,525,252.00 · Class: 6.15%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001355
- Form type
- SCHEDULE 13G
- Filer
- Anebulo Pharmaceuticals, Inc.
- CIK
- CIK 1815974
- Filed
- Mar 17, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership